Eric Benevich
2017
In 2017, Eric Benevich earned a total compensation of $3M as Chief Commercial Officer at Neurocrine Biosciences, a 20% increase compared to previous year.
Compensation breakdown
| Bonus | $246,000 |
|---|---|
| Option Awards | $1,825,536 |
| Salary | $410,000 |
| Stock Awards | $458,344 |
| Other | $37,722 |
| Total | $2,977,602 |
Benevich received $1.8M in option awards, accounting for 61% of the total pay in 2017.
Benevich also received $246K in bonus, $410K in salary, $458.3K in stock awards and $37.7K in other compensation.
Rankings
In 2017, Eric Benevich's compensation ranked 3,668th out of 14,666 executives tracked by ExecPay. In other words, Benevich earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,668 out of 14,666 | 75th |
Division Manufacturing | 1,265 out of 5,772 | 78th |
Major group Chemicals And Allied Products | 356 out of 2,075 | 83rd |
Industry group Drugs | 274 out of 1,731 | 84th |
Industry Biological Products, Except Diagnostic Substances | 53 out of 313 | 83rd |
Source: SEC filing on April 17, 2019.
Benevich's colleagues
We found four more compensation records of executives who worked with Eric Benevich at Neurocrine Biosciences in 2017.
News
Neurocrine Biosciences CEO Kevin Gorman's 2021 pay rises 1% to $14M
April 7, 2022
Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M
April 9, 2021
Neurocrine Biosciences CEO Kevin Gorman's 2019 pay rises 9% to $9.5M
April 9, 2020
Neurocrine Biosciences CEO Kevin Gorman's 2018 pay rises 14% to $8.6M
April 17, 2019